$XOMA Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in XOMA Corp.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in XOMA Corp. Get notifications about new insider transactions in XOMA Corp for free.

Page:   < prev 1 ... 2 3 4 5 6 7 8 8 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 20 2014XOMAXOMA CorpSCANNON PATRICK J MD PHDExec. VP & CSOSellS6.323,41921,59491,54695 K to 91.5 K (-3.60 %)
Mar 20 2014XOMAXOMA CorpSCANNON PATRICK J MD PHDExec. VP & CSOBuyM0.009,500094,96585.5 K to 95 K (+11.12 %)
Mar 20 2014XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...Option ExerciseM0.0018,205018,205
Mar 20 2014XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...Option ExerciseM0.0012,142024,282
Mar 20 2014XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...Option ExerciseM3.046,00018,24092,040
Mar 20 2014XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...SellS6.316,00037,84890,71996.7 K to 90.7 K (-6.20 %)
Mar 20 2014XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...BuyM3.046,00018,24096,71990.7 K to 96.7 K (+6.61 %)
Mar 20 2014XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...SellS6.326,98844,13690,71997.7 K to 90.7 K (-7.15 %)
Mar 20 2014XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...BuyM0.0018,205097,70779.5 K to 97.7 K (+22.90 %)
Mar 20 2014XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...SellS6.324,66129,43979,50284.2 K to 79.5 K (-5.54 %)
Mar 20 2014XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...BuyM0.0012,142084,16372 K to 84.2 K (+16.86 %)
Mar 18 2014XOMAXOMA CorpVarian JohnCEOOption ExerciseM1.2410,00012,400220,392
Mar 18 2014XOMAXOMA CorpVarian JohnCEOSellS6.0310,00060,292270,035280 K to 270 K (-3.57 %)
Mar 18 2014XOMAXOMA CorpVarian JohnCEOBuyM1.2410,00012,400280,035270 K to 280 K (+3.70 %)
Mar 11 2014XOMAXOMA CorpLIMBER JOSEPH MDirectorOption ExerciseM0.005,600011,200
Mar 11 2014XOMAXOMA CorpLIMBER JOSEPH MDirectorBuyM0.005,60005,6000 to 5.6 K
Mar 03 2014XOMAXOMA CorpSCANNON PATRICK J MD PHDExec. VP & CSOOption ExerciseA8.9160,000534,60060,000
Mar 03 2014XOMAXOMA CorpSCANNON PATRICK J MD PHDExec. VP & CSOGrantA0.0043,448085,46542 K to 85.5 K (+103.41 %)
Mar 03 2014XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...Option ExerciseA8.9195,000846,45095,000
Mar 03 2014XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...GrantA0.0068,793072,0213.2 K to 72 K (+2,131.13 %)
Mar 03 2014XOMAXOMA CorpKURLAND FREDCFO & VP FinanceOption ExerciseA8.9160,000534,60060,000
Mar 03 2014XOMAXOMA CorpKURLAND FREDCFO & VP FinanceGrantA0.0043,448057,64014.2 K to 57.6 K (+306.14 %)
Mar 03 2014XOMAXOMA CorpKlein ThomasChief Commercial Of ...Option ExerciseA8.9160,000534,60060,000
Mar 03 2014XOMAXOMA CorpKlein ThomasChief Commercial Of ...GrantA0.0043,448043,4480 to 43.4 K
Mar 03 2014XOMAXOMA CorpVarian JohnCEOOption ExerciseA8.91167,5041,492,461167,504
Mar 03 2014XOMAXOMA CorpVarian JohnCEOGrantA0.00121,2960270,035148.7 K to 270 K (+81.55 %)
Feb 19 2014XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...Option ExerciseM3.046,00018,24098,040
Feb 19 2014XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...SellS7.556,00045,2723,2289.2 K to 3.2 K (-65.02 %)
Feb 19 2014XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...BuyM3.046,00018,2409,2283.2 K to 9.2 K (+185.87 %)
Feb 19 2014XOMAXOMA CorpVarian JohnCEOOption ExerciseM1.2410,00012,400230,392
Feb 19 2014XOMAXOMA CorpVarian JohnCEOSellS7.5510,00075,478148,739158.7 K to 148.7 K (-6.30 %)
Feb 19 2014XOMAXOMA CorpVarian JohnCEOBuyM1.2410,00012,400158,739148.7 K to 158.7 K (+6.72 %)
Feb 10 2014XOMAXOMA CorpKURLAND FREDCFO & VP FinanceGiftG0.007,639014,44622.1 K to 14.4 K (-34.59 %)
Jan 23 2014XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...Option ExerciseM3.045,69417,310104,040
Jan 23 2014XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...SellS8.275,69447,0783,2288.9 K to 3.2 K (-63.82 %)
Jan 23 2014XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...BuyM3.045,69417,3108,9223.2 K to 8.9 K (+176.39 %)
Jan 23 2014XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...SellS8.273062,5303,2283.5 K to 3.2 K (-8.66 %)
Jan 17 2014XOMAXOMA CorpVarian JohnCEOOption ExerciseM1.2410,00012,400240,392
Jan 17 2014XOMAXOMA CorpVarian JohnCEOSellS8.2810,00082,791148,739158.7 K to 148.7 K (-6.30 %)
Jan 17 2014XOMAXOMA CorpVarian JohnCEOBuyM1.2410,00012,400158,739148.7 K to 158.7 K (+6.72 %)
Jan 10 2014XOMAXOMA CorpSCANNON PATRICK J MD PHDExec. VP & CSOOption ExerciseM1.6920,00033,80018,406
Jan 10 2014XOMAXOMA CorpSCANNON PATRICK J MD PHDExec. VP & CSOSellS8.0020,000160,04242,01762 K to 42 K (-32.25 %)
Jan 10 2014XOMAXOMA CorpSCANNON PATRICK J MD PHDExec. VP & CSOBuyM1.6920,00033,80062,01742 K to 62 K (+47.60 %)
Dec 18 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...Option ExerciseM3.046,00018,240109,734
Dec 18 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...SellS5.676,00033,9923,5349.5 K to 3.5 K (-62.93 %)
Dec 18 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...BuyM3.046,00018,2409,5343.5 K to 9.5 K (+169.78 %)
Dec 18 2013XOMAXOMA CorpVarian JohnCEOOption ExerciseM1.2410,00012,400250,392
Dec 18 2013XOMAXOMA CorpVarian JohnCEOSellS5.4410,00054,372148,739158.7 K to 148.7 K (-6.30 %)
Dec 18 2013XOMAXOMA CorpVarian JohnCEOBuyM1.2410,00012,400158,739148.7 K to 158.7 K (+6.72 %)
Dec 03 2013XOMAXOMA CorpSCANNON PATRICK J MD PHDExec. VP & CSOOption ExerciseM1.6916,66528,16438,406
Dec 03 2013XOMAXOMA CorpSCANNON PATRICK J MD PHDExec. VP & CSOOption ExerciseM1.693,3355,6369,939
Dec 03 2013XOMAXOMA CorpSCANNON PATRICK J MD PHDExec. VP & CSOSellS6.0016,66599,99242,01758.7 K to 42 K (-28.40 %)
Dec 03 2013XOMAXOMA CorpSCANNON PATRICK J MD PHDExec. VP & CSOBuyM1.6916,66528,16458,68242 K to 58.7 K (+39.66 %)
Dec 03 2013XOMAXOMA CorpSCANNON PATRICK J MD PHDExec. VP & CSOSellS6.003,33520,01042,01745.4 K to 42 K (-7.35 %)
Dec 03 2013XOMAXOMA CorpSCANNON PATRICK J MD PHDExec. VP & CSOBuyM1.693,3355,63645,35242 K to 45.4 K (+7.94 %)
Dec 02 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...Option ExerciseM3.044,69614,276115,734
Dec 02 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...SellS4.544,69621,3203,5348.2 K to 3.5 K (-57.06 %)
Dec 02 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...BuyM3.044,69614,2768,2303.5 K to 8.2 K (+132.88 %)
Nov 19 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...Option ExerciseM2.361,3043,07715,887
Nov 19 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...SellS4.081,3045,3173,5344.8 K to 3.5 K (-26.95 %)
Nov 19 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...BuyM2.361,3043,0774,8383.5 K to 4.8 K (+36.90 %)
Nov 15 2013XOMAXOMA CorpVarian JohnCEOOption ExerciseM0.0096,167088,482
Nov 15 2013XOMAXOMA CorpVarian JohnCEOOption ExerciseM0.004,4980184,649
Nov 15 2013XOMAXOMA CorpVarian JohnCEOOption ExerciseM1.2410,00012,400260,392
Nov 15 2013XOMAXOMA CorpVarian JohnCEOSellS4.1310,00041,329148,739158.7 K to 148.7 K (-6.30 %)
Nov 15 2013XOMAXOMA CorpVarian JohnCEOBuyM1.2410,00012,400158,739148.7 K to 158.7 K (+6.72 %)
Nov 15 2013XOMAXOMA CorpVarian JohnCEOSellS3.9152,477205,332148,739201.2 K to 148.7 K (-26.08 %)
Nov 15 2013XOMAXOMA CorpVarian JohnCEOBuyM0.0096,1670201,216105 K to 201.2 K (+91.54 %)
Nov 15 2013XOMAXOMA CorpVarian JohnCEOSellS3.912,4559,606105,049107.5 K to 105 K (-2.28 %)
Nov 15 2013XOMAXOMA CorpVarian JohnCEOBuyM0.004,4980107,504103 K to 107.5 K (+4.37 %)
Nov 15 2013XOMAXOMA CorpWYSZOMIERSKI JACK LDirectorOption ExerciseM0.004,49803,902
Nov 15 2013XOMAXOMA CorpWYSZOMIERSKI JACK LDirectorBuyM0.004,498011,7977.3 K to 11.8 K (+61.62 %)
Nov 15 2013XOMAXOMA CorpBOWES WILLIAM K JRDirectorOption ExerciseM0.004,49801,102
Nov 15 2013XOMAXOMA CorpBOWES WILLIAM K JRDirectorBuyM0.004,498012,8688.4 K to 12.9 K (+53.74 %)
Nov 15 2013XOMAXOMA CorpWalbert Timothy PDirectorOption ExerciseM0.004,49801,102
Nov 15 2013XOMAXOMA CorpWalbert Timothy PDirectorBuyM0.004,498011,7977.3 K to 11.8 K (+61.62 %)
Nov 15 2013XOMAXOMA CorpVAN NESS W DENMANDirectorOption ExerciseM0.006,87606,875
Nov 15 2013XOMAXOMA CorpVAN NESS W DENMANDirectorBuyM0.006,876016,90210 K to 16.9 K (+68.58 %)
Nov 15 2013XOMAXOMA CorpSCANNON PATRICK J MD PHDExec. VP & CSOOption ExerciseM0.0022,65209,876
Nov 15 2013XOMAXOMA CorpSCANNON PATRICK J MD PHDExec. VP & CSOSellS3.918,34632,66042,01750.4 K to 42 K (-16.57 %)
Nov 15 2013XOMAXOMA CorpSCANNON PATRICK J MD PHDExec. VP & CSOBuyM0.0022,652050,36327.7 K to 50.4 K (+81.74 %)
Nov 15 2013XOMAXOMA CorpKURLAND FREDCFO & VP FinanceOption ExerciseM0.0022,596015,531
Nov 15 2013XOMAXOMA CorpKURLAND FREDCFO & VP FinanceSellS3.9112,33148,24422,08534.4 K to 22.1 K (-35.83 %)
Nov 15 2013XOMAXOMA CorpKURLAND FREDCFO & VP FinanceBuyM0.0022,596034,41611.8 K to 34.4 K (+191.17 %)
Oct 21 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...Option ExerciseM2.367461,76117,191
Oct 21 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...SellS4.717463,5118,7889.5 K to 8.8 K (-7.82 %)
Oct 21 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...BuyM2.367461,7619,5348.8 K to 9.5 K (+8.49 %)
Oct 16 2013XOMAXOMA CorpVarian JohnDirector and CEOOption ExerciseM1.2410,00012,400270,392
Oct 16 2013XOMAXOMA CorpVarian JohnDirector and CEOSellS4.6010,00045,950103,006113 K to 103 K (-8.85 %)
Oct 16 2013XOMAXOMA CorpVarian JohnDirector and CEOBuyM1.2410,00012,400113,006103 K to 113 K (+9.71 %)
Oct 02 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...BuyL4.274591,9588,7888.3 K to 8.8 K (+5.51 %)
Sep 19 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...SellS4.536,00027,1878,32914.3 K to 8.3 K (-41.87 %)
Sep 17 2013XOMAXOMA CorpVarian JohnDirector and CEOOption ExerciseM1.2410,00012,400280,392
Sep 17 2013XOMAXOMA CorpVarian JohnDirector and CEOSellS4.5910,00045,862103,006113 K to 103 K (-8.85 %)
Sep 17 2013XOMAXOMA CorpVarian JohnDirector and CEOBuyM1.2410,00012,400113,006103 K to 113 K (+9.71 %)
Aug 21 2013XOMAXOMA CorpBAKER BROS. ADVISORS LPDirectorGrantA3.6221,41077,504510,449489 K to 510.4 K (+4.38 %)
Aug 21 2013XOMAXOMA CorpBAKER BROS. ADVISORS LPDirectorGrantA3.621,854,0586,711,69019,767,77017.9 M to 19.8 M (+10.35 %)
Aug 21 2013XOMAXOMA CorpBAKER BROS. ADVISORS LPDirectorGrantA3.62882,3233,194,0092,829,7531.9 M to 2.8 M (+45.31 %)
Aug 19 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...SellS3.746,00022,41914,32920.3 K to 14.3 K (-29.51 %)
Aug 16 2013XOMAXOMA CorpKURLAND FREDCFO & VP FinanceOption ExerciseM0.0019,064038,127
Aug 16 2013XOMAXOMA CorpKURLAND FREDCFO & VP FinanceGiftG0.0013,231011,82025.1 K to 11.8 K (-52.82 %)
Aug 16 2013XOMAXOMA CorpKURLAND FREDCFO & VP FinanceSellS3.867,49828,95125,05132.5 K to 25.1 K (-23.04 %)
Aug 16 2013XOMAXOMA CorpKURLAND FREDCFO & VP FinanceBuyM0.0019,064032,54913.5 K to 32.5 K (+141.37 %)
Aug 16 2013XOMAXOMA CorpVarian JohnDirector and CEOOption ExerciseM0.0094,5740189,147
Aug 16 2013XOMAXOMA CorpVarian JohnDirector and CEOOption ExerciseM1.2410,00012,400290,392
Aug 16 2013XOMAXOMA CorpVarian JohnDirector and CEOSellS3.9210,00039,212103,006113 K to 103 K (-8.85 %)
Aug 16 2013XOMAXOMA CorpVarian JohnDirector and CEOBuyM1.2410,00012,400113,006103 K to 113 K (+9.71 %)
Aug 16 2013XOMAXOMA CorpVarian JohnDirector and CEOBuyM0.0094,5740103,0068.4 K to 103 K (+1,121.61 %)
Aug 16 2013XOMAXOMA CorpVarian JohnDirector and CEOSellS3.8651,647199,4198,43260.1 K to 8.4 K (-85.97 %)
Aug 16 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...Option ExerciseM0.0026,748053,496
Aug 16 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...SellS3.8610,52040,62120,32930.8 K to 20.3 K (-34.10 %)
Aug 16 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...BuyM0.0026,748030,8494.1 K to 30.8 K (+652.23 %)
Aug 16 2013XOMAXOMA CorpSCANNON PATRICK J MD PHDExec. VP & CSOOption ExerciseM0.0016,265032,528
Aug 16 2013XOMAXOMA CorpSCANNON PATRICK J MD PHDExec. VP & CSOSellS3.866,00223,17527,71133.7 K to 27.7 K (-17.80 %)
Aug 16 2013XOMAXOMA CorpSCANNON PATRICK J MD PHDExec. VP & CSOBuyM0.0016,265033,71317.4 K to 33.7 K (+93.22 %)
Jul 19 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...Option ExerciseM2.362,7486,48517,937
Jul 19 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...Option ExerciseM3.043,2529,886120,430
Jul 19 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...SellS4.713,25215,3024,1017.4 K to 4.1 K (-44.23 %)
Jul 19 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...BuyM3.043,2529,8867,3534.1 K to 7.4 K (+79.30 %)
Jul 19 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...SellS4.712,74812,9314,1016.8 K to 4.1 K (-40.12 %)
Jul 19 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...BuyM2.362,7486,4856,8494.1 K to 6.8 K (+67.01 %)
Jul 17 2013XOMAXOMA CorpVarian JohnDirector and CEOOption ExerciseM1.2410,00012,400300,392
Jul 17 2013XOMAXOMA CorpVarian JohnDirector and CEOSellS4.8110,00048,06660,07970.1 K to 60.1 K (-14.27 %)
Jul 17 2013XOMAXOMA CorpVarian JohnDirector and CEOBuyM1.2410,00012,40070,07960.1 K to 70.1 K (+16.64 %)
Jul 01 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...BuyM3.455671,9554,1013.5 K to 4.1 K (+16.04 %)
Jun 18 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...Option ExerciseM2.363,1307,38720,685
Jun 18 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...SellS0.002,87003,5346.4 K to 3.5 K (-44.82 %)
Jun 18 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...SellS0.003,13006,4049.5 K to 6.4 K (-32.83 %)
Jun 18 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...BuyM2.363,1307,3879,5346.4 K to 9.5 K (+48.88 %)
Jun 18 2013XOMAXOMA CorpVarian JohnDirector and CEOOption ExerciseM1.2410,00012,400310,392
Jun 18 2013XOMAXOMA CorpVarian JohnDirector and CEOSellS0.0010,000060,07970.1 K to 60.1 K (-14.27 %)
Jun 18 2013XOMAXOMA CorpVarian JohnDirector and CEOBuyM1.2410,00012,40070,07960.1 K to 70.1 K (+16.64 %)
Jun 12 2013XOMAXOMA CorpSCANNON PATRICK J MD PHDExec. VP & CSOOption ExerciseM1.6910,00016,90013,274
Jun 12 2013XOMAXOMA CorpSCANNON PATRICK J MD PHDExec. VP & CSOSellS0.0010,000017,44827.4 K to 17.4 K (-36.43 %)
Jun 12 2013XOMAXOMA CorpSCANNON PATRICK J MD PHDExec. VP & CSOBuyM1.6910,00016,90027,44817.4 K to 27.4 K (+57.31 %)
May 29 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...Option ExerciseM0.004,66709,333
May 29 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...SellS4.161,7977,4766,4048.2 K to 6.4 K (-21.91 %)
May 29 2013XOMAXOMA CorpRUBIN PAUL DSr. VP Clinical Dev ...BuyM0.004,66708,2013.5 K to 8.2 K (+132.06 %)
May 29 2013XOMAXOMA CorpWYSZOMIERSKI JACK LDirectorOption ExerciseM2.692,8007,5328,866
May 29 2013XOMAXOMA CorpWYSZOMIERSKI JACK LDirectorBuyM2.692,8007,5327,2994.5 K to 7.3 K (+62.24 %)
May 29 2013XOMAXOMA CorpWalbert Timothy PDirectorOption ExerciseM0.002,80005,600
May 29 2013XOMAXOMA CorpWalbert Timothy PDirectorBuyM0.002,80007,2994.5 K to 7.3 K (+62.24 %)
May 29 2013XOMAXOMA CorpBOWES WILLIAM K JRDirectorOption ExerciseM0.002,80005,600
May 29 2013XOMAXOMA CorpBOWES WILLIAM K JRDirectorBuyM0.002,80008,3705.6 K to 8.4 K (+50.27 %)
May 29 2013XOMAXOMA CorpVAN NESS W DENMANDirectorOption ExerciseM0.003,15006,300
May 29 2013XOMAXOMA CorpVAN NESS W DENMANDirectorBuyM0.003,150010,0266.9 K to 10 K (+45.81 %)
May 24 2013XOMAXOMA CorpWYSZOMIERSKI JACK LDirectorOption ExerciseA0.008,40008,400
May 24 2013XOMAXOMA CorpWYSZOMIERSKI JACK LDirectorOption ExerciseA4.1311,60047,90811,600
May 24 2013XOMAXOMA CorpWalbert Timothy PDirectorOption ExerciseA0.008,40008,400
May 24 2013XOMAXOMA CorpWalbert Timothy PDirectorOption ExerciseA4.1311,60047,90811,600

Page:   < prev 1 ... 2 3 4 5 6 7 8 8 next >

Contact us | Follow us on Twitter